Pfizer Zyrtec-D promotions
Professional sales aid and product website for Zyrtec-D (certirizine/pseudoephedrine) fail to include contraindications and warnings regarding the antihistamine's pseudoephedrine component, April 22 1FDA ad division letter says. Associate Commissioner Peter Pitts recently pointed to Pfizer's website as a model for internet promotion (2"The Pink Sheet" April 5, 2004, p. 18)...
You may also be interested in...
Although FDA is issuing fewer warning letters, those issued are more likely to signal a potential enforcement action, FDA Associate Commissioner Peter Pitts suggested during the DTC National Conference & Expo in Boston March 30
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.